Back to Results
First PageMeta Content
Alcohols / Euphoriants / Drug rehabilitation / Phenols / Buprenorphine / Opioid dependence / Drug Addiction Treatment Act / Methadone / Naloxone / Chemistry / Organic chemistry / Morphinans


TENNCARE POLICY MANUAL Policy No: Subject: Approval: BEN[removed]rev. 3)
Add to Reading List

Document Date: 2014-07-25 16:02:54

Open Document

File Size: 673,73 KB

Share Result on Facebook

City

Rockville / /

Company

Reckitt Benckiser / Reckitt Benckiser Pharmaceuticals Inc. / /

Event

Product Issues / Product Recall / /

Facility

Pharmacy Division Office / /

IndustryTerm

buprenorphine products / treatment of depression / drug manufacturer / /

MedicalCondition

allergy / pain / respiratory depression / withdrawal symptoms / depression / /

MedicalTreatment

counseling / /

Organization

federal government / Food and Drug Administration / State Agency / FDA / National Technical Information Service / Substance Abuse and Mental Health Services Administration / Drug Enforcement Administration / Pharmacy Division office of the Chief Medical officer REFERENCES / /

Person

Schedule Ill / IV / /

Position

prescribing physician / benefits manager / individual physician / physician / /

Product

All prescriptions / naloxone / symptoms / buprenorphine hydrochloride / naloxone hydrochloride / /

Technology

Treatment Improvement Protocol / pdf / /

URL

http /

SocialTag